Purpose of the Study

Helios Clinical Research is conducting a clinical research study related to chemotherapy-induced neuropathic pain. The purpose of this study is to explore the safety and efficacy of HAL in the treatment of patients with moderate to severe CINP. The research team is seeking adults who meet the eligibility criteria, including male or female patients aged ≥18 years, to learn whether they may qualify.

Study Requirements

  • have received a cancer chemotherapy regimen that included taxanes and/or platinum and have no active or discernible disease progression at the time of screening.
  • neuropathic pain has been present for a minimum of 90 days preceding the Screening visit, and is attributed to platinum and/or taxane chemotherapy.

Potential Benefits of Participation

Maginfying

Access to new treatments that are
not yet available to the general public.

Hand Heart

Personalized medical attention from
leading healthcare professionals.

Helios

Compensation provided to qualified participants

Study Locations

These studies are currently enrolling at the following sites:

The Oncology Institute Powered by Helios - Lakeland, FL

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.